Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Animals : an Open Access Journal From MDPI
|
July 27, 2022
One-Step In Vitro Generation of ETV2-Null Pig Embryos
Marta Moya-Jódar, Giulia Coppiello, Juan Roberto Rodríguez-Madoz, et al.
Annals of Hematology
|
May 11, 2026
Academic BCMA CAR-T (ARI0002h) achieves MRD-negative remission with sBCMA biomarker response in relapsed POEMS syndrome after double ASCT
Víctor Torrecillas-Mayayo, Aina Oliver-Caldes, Nuria Martínez-Cibrian, et al.
Journal of Clinical Immunology
|
September 27, 2021
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona
Xavier Solanich, Raúl Rigo-Bonnin, Victor-David Gumucio, et al.
PLOS Digital Health
|
January 9, 2025
A data management system for precision medicine
John J L Jacobs, Inés Beekers, Inge Verkouter, et al.
British Journal of Haematology
|
June 4, 2026
Cesni-cel (ARI0002h) in ultra-high-risk multiple myeloma with plasma cell leukaemia or central nervous system involvement
Carlos Jimenez-Mira, Natalia Tovar, Núria Martínez-Cibrián, et al.
International Journal of Molecular Sciences
|
October 16, 2025
Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report
Daniel Munarriz, Oriana López-Godino, Nuria Martinez-Cibrian, et al.
British Journal of Haematology
|
October 31, 2023
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma
Núria Martínez-Cibrián, Valentín Ortiz-Maldonado, Marta Español-Rego, et al.
British Journal of Haematology
|
June 19, 2024
Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T-cells
Iñaki Ortiz de Landazuri, Aina Oliver-Caldés, Marta Español-Rego, et al.
Hemasphere
|
September 15, 2025
Efficacy and safety of the academic anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphoma
Núria Martínez-Cibrián, Valentín Ortiz-Maldonado, Marta Español-Rego, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2024
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma
Aina Oliver-Caldes, Marta Español-Rego, Aintzane Zabaleta, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Animals : an Open Access Journal From MDPI
|
July 27, 2022
One-Step In Vitro Generation of ETV2-Null Pig Embryos
Marta Moya-Jódar, Giulia Coppiello, Juan Roberto Rodríguez-Madoz, et al.
Annals of Hematology
|
May 11, 2026
Academic BCMA CAR-T (ARI0002h) achieves MRD-negative remission with sBCMA biomarker response in relapsed POEMS syndrome after double ASCT
Víctor Torrecillas-Mayayo, Aina Oliver-Caldes, Nuria Martínez-Cibrian, et al.
Journal of Clinical Immunology
|
September 27, 2021
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona
Xavier Solanich, Raúl Rigo-Bonnin, Victor-David Gumucio, et al.
PLOS Digital Health
|
January 9, 2025
A data management system for precision medicine
John J L Jacobs, Inés Beekers, Inge Verkouter, et al.
British Journal of Haematology
|
June 4, 2026
Cesni-cel (ARI0002h) in ultra-high-risk multiple myeloma with plasma cell leukaemia or central nervous system involvement
Carlos Jimenez-Mira, Natalia Tovar, Núria Martínez-Cibrián, et al.
International Journal of Molecular Sciences
|
October 16, 2025
Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case Report
Daniel Munarriz, Oriana López-Godino, Nuria Martinez-Cibrian, et al.
British Journal of Haematology
|
October 31, 2023
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma
Núria Martínez-Cibrián, Valentín Ortiz-Maldonado, Marta Español-Rego, et al.
British Journal of Haematology
|
June 19, 2024
Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T-cells
Iñaki Ortiz de Landazuri, Aina Oliver-Caldés, Marta Español-Rego, et al.
Hemasphere
|
September 15, 2025
Efficacy and safety of the academic anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphoma
Núria Martínez-Cibrián, Valentín Ortiz-Maldonado, Marta Español-Rego, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2024
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma
Aina Oliver-Caldes, Marta Español-Rego, Aintzane Zabaleta, et al.
Page
of 7